58 Development and characterization of novel orally available Hypoxiainducible factor (HIF) signaling inhibitors as dual-mechanism cancer therapeutics

Autor:	A. Encinas-Lopez, J. D. Lewis, R. Thermann, D. Thomson, B. Janssen, M. Mülbaier, Brian Leber, J. Alonso, S. Wawro, Christof Schultes
Rok vydání:	2010
Předmět:	Cancer Research Oncology business.industry Cancer research Medicine Cancer business medicine.disease Dual mechanism
Zdroj:	European Journal of Cancer Supplements. 8:27
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(10)71763-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9d1ca00112afaff1ff570d9bb3ac1e77 https://doi.org/10.1016/s1359-6349(10)71763-8 Zobrazit plný text záznamu Full Text from ScienceDirect